Suchergebnisse - "Kierkuś, Jarosław"

PubPharm (156)

1

Combination biologic therapy in pediatric inflammatory bowel disease : Safety and efficacy over a minimum 12-month follow-up period

enthalten in: Journal of pediatric gastroenterology and nutrition | 2024

von Wlazlo, M. | Meglicka, M. | Wiernicka, A. | +3

2

New noninvasive biomarkers of intestinal inflammation and increased intestinal permeability in pediatric inflammatory bowel diseases and their correlation with fecal calprotectin : a pilot study

enthalten in: Minerva gastroenterology | 2023

von Szymanska, E. | Bierla, J. | Dadalski, M. | +4

3

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis : QUASAR Phase 2b Induction Study

enthalten in: Gastroenterology | 2023

von Peyrin-Biroulet, L. | Allegretti, J. | Rubin, D. | +115

4

Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis : a phase 3, randomised, double-blind study

enthalten in: EClinicalMedicine | 2023

von Croft, N. | Korczowski, B. | Kierkuś, J. | +2

5

Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA) : a randomised, double-blind, controlled, phase 2, proof-of-concept trial

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Feagan, B. | Sands, B. | Sandborn, W. | +61

CommentIn: Lancet Gastroenterol Hepatol. 2023 Apr;8(4):288-290. - PMID 36738761

6

Biological markers of disease activity in inflammatory bowel diseases

enthalten in: Przeglad gastroenterologiczny | 2023

von Szymanska, E. | Szymanska, S. | Dadalski, M. | +1

7

Sexual functions in individuals with inflammatory bowel diseases

enthalten in: Przeglad gastroenterologiczny | 2023

von Kotkowicz-Szczur, M. | Szymańska, E. | Kisielewski, R. | +1

8

Dual Biologic Therapy in Moderate to Severe Pediatric Inflammatory Bowel Disease : A Retrospective Study

enthalten in: Children (Basel, Switzerland) | 2022

von Wlazło, M. | Meglicka, M. | Wiernicka, A. | +2

9

Bridging Fixed Dose to Body Weight-based Regimen of Adalimumab in Paediatric Ulcerative Colitis Using a Pharmacometric Modelling Approach : Case Study with the Phase 3 ENVISION I Trial

enthalten in: Journal of Crohn's & colitis | 2022

von Stodtmann, S. | Chen, M. | Siovitz, L. | +6

10

Correction to : Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial

enthalten in: Inflammatory bowel diseases | 2022

von Zhang, W. | Scalori, A. | Fuh, F. | +9

ErratumFor: Inflamm Bowel Dis. 2022 Sep 1;28(9):1348-1356. - PMID 34849918

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]